Skip to main content
Home
 
 
 
MENU
Home
Janssen’s COVID-19 Vaccine Status >

Janssen Global Main Menu

  • Our Company
    • About Us
    • Contact Us
    • Grants & Giving
    • News Center
    • Our Leaders
    • Patient Safety information
    • Products
    • Sustainability
    • Transparency
    • VISIT JANSSEN IN YOUR COUNTRY
  • Our Focus
    • Therapeutic Areas
    • Cardiovascular, Metabolism and Retina
    • Immunology
    • Infectious Diseases & Vaccines
    • Neuroscience
    • Oncology
    • Pulmonary Hypertension
    • Patient Engagement
  • Our Science
    • Our Response to COVID-19
    • Clinical Trials
    • Compassionate Use & Pre-Approval Access
    • R&D Data Science
    • Janssen Global Trial Finder
    • World Without Disease Accelerator
    • Janssen Clinical Innovation
    • Precision Medicine & Janssen Diagnostics

Our Stories List

Making a Splash for Disease Awareness
Global_Trial_Finder
Making a Splash for Disease Awareness
Looking Under the Hood for Green Chemistry Solutions
Global_Trial_Finder
Looking Under the Hood for Green Chemistry Solutions
  • Return to home

Global Trial Finder

  • text size

My Saved Trials

A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease (Reτain)

Last Updated   May 14, 2025

Want to learn how to participate in this trial?

64042056ALZ2001

OVERVIEW

  • Sexes Eligible for Study
    all
  • Age
    55+ years
  • Phase
    phase 2
    2
  • Sites
    75 Sites
  • Status
    Recruiting

SUMMARY

The purpose of this study is to assess the effect of JNJ-64042056 on cognitive decline, as measured by Preclinical Alzheimer's disease Cognitive Composite 5 (PACC-5) compared with placebo.

CONDITIONS

  • Preclinical Alzheimer's Disease

ELIGIBILITY


Inclusion Criteria:

* Elevated brain tau pathology defined as Braak 3 region of interest standardized uptake value ratio (ROI SUVR) greater than (>) 1.1 on a screening tau PET scan, reviewed centrally by a qualified reader
* Clinical Dementia Rating (CDR) global score of 0 at screening and baseline
* Mini Mental State Examination (MMSE) greater than or equal to (>=) 27 (with educational adjustment)
* Able to read and write and with a minimum 5 years of formal education as reported by participant and study partner at screening
* A participant must be of non-childbearing potential


Exclusion Criteria:

* History consistent with or known autosomal dominant AD (mutation identified in the family and/or participant)
* Fulfills diagnostic criteria for Alzheimer's Dementia or non-Alzheimer's Dementia, including, but not limited to Frontotemporal Dementia (FTD), Diffuse Lewy Body Dementia (DLBD), Vascular Dementia (VAD), alcoholic dementia, Parkinson's dementia, Korsakov, Creutzfeldt-Jakob or other prion diseases, Posterior Cortical Atrophy
* Diagnosis of Mild Cognitive Impairment (MCI)
* Vitamin B12 or folate levels below the central laboratory lower limit of normal, unless in the opinion of the investigator it does not require treatment
* History of or current neurological disease other than preclinical AD that may make interpretation of possible new neurological signs or symptoms difficult


Inclusion Criteria:

* Elevated brain tau pathology defined as Braak 3 region of interest standardized uptake value ratio (ROI SUVR) greater than (>) 1.1 on a screening tau PET scan, reviewed centrally by a qualified reader
* Clinical Dementia Rating (CDR) global score of 0 at scr

More...

DETAILS

LOCATIONS

Locations in:
United States, Japan, Australia, France, Spain, Sweden, United Kingdom
Country (7) City or Province (75) Status
United States Riverside Artemis Institute for Clinical Research
RECRUITING
United States San Diego Artemis Institute for Clinical Research
RECRUITING
United States Atlantis JEM Research LLC
RECRUITING
United States Clermont K2 Medical Research Winter Garden
RECRUITING
United States Maitland K2 Medical Research
RECRUITING
United States Merritt Island Merritt Island Medical Research, LLC
RECRUITING
United States Orlando Headlands Research Orlando
RECRUITING
United States Stuart Alzheimers Research and Treatment Center
RECRUITING
United States Wellington Alzheimers Research and Treatment Center
RECRUITING
United States Hattiesburg Hattiesburg Clinic
RECRUITING
United States East Syracuse Velocity Clinical Research
RECRUITING
United States Centerville Valley Medical Research
RECRUITING
United States Plymouth Meeting Keystone Clinical Studies LLC
RECRUITING
Japan Chuo-ku Tokyo Asbo Clinic
RECRUITING
Japan Hirakata-shi Hatsuta Neurology Clinic
RECRUITING
Japan Kobe Kusunoki Clinic
RECRUITING
Japan Toyonaka-shi Nagomi Clinic
RECRUITING
United States Phoenix Xenoscience Inc.
RECRUITING
United States Irvine Irvine Clinical Research
RECRUITING
United States Boca Raton Excel Medical Clinical Trials, LLC
RECRUITING
United States Jacksonville Clinical NeuroScience Solutions Inc
RECRUITING
United States Lady Lake K2 Medical Research
RECRUITING
United States Tampa K2 Medical Research
RECRUITING
United States The Villages Charter Research
RECRUITING
United States West Palm Beach Palm Beach Neurology and Premier Research Institute
RECRUITING
United States Chicago Great Lakes Clinical Trials
RECRUITING
United States Gurnee Great Lakes Clinical Trials
RECRUITING
United States Farmington Hills Quest Research Institute
RECRUITING
United States Springfield The Cognitive and Research Center of New Jersey LLC
RECRUITING
United States Albany Neurological Associates of Albany, PC
RECRUITING
United States New York The Medical Research Network, LLC
RECRUITING
United States Matthews AMC Research, LLC
RECRUITING
United States Providence Butler Hospital
RECRUITING
United States San Antonio Clinical Trials of Texas Inc
RECRUITING
United States Bennington Memory Clinic Inc
RECRUITING
United States Charlottesville University of Virginia
RECRUITING
Australia Carlton Neuro Trials Victoria
RECRUITING
Australia Chermside The Prince Charles Hospital
RECRUITING
Australia Darlinghurst St Vincent's Centre for Applied Medical Research
RECRUITING
Australia Ivanhoe Austin Health Heidelberg Repatriation Hospital
RECRUITING
Australia Kogarah Southern Neurology
RECRUITING
Australia Macquarie Park KaRa Institute of Neurological Diseases
RECRUITING
Australia Nedlands Australian Alzheimer's Research Foundation Incorporated
RECRUITING
France Toulouse CHU Toulouse - Hôpital La Grave
RECRUITING
Japan Chofu-shi Enomoto Internal Medicine Clinic
RECRUITING
Japan Kobe City Kobe City Medical Center General Hospital
RECRUITING
Japan Musashimurayama Musashimurayama Hospital
RECRUITING
Japan Narashino-shi Saiseikai Narashino Hospital
RECRUITING
Japan Shinjuku ku ToCROM Clinic
RECRUITING
Japan Shinjuku-ku Higashi-Shinjuku Clinic
RECRUITING
Japan Shinjyuku Ku Medical corporation Shinanokai Samoncho Clinic
RECRUITING
Japan Suita shi OCROM Clinic
RECRUITING
Spain Barcelona Barcelona Beta Brain Research Center
RECRUITING
Spain Barcelona Hosp Clinic de Barcelona
RECRUITING
Spain Getxo Centro At. Esp. Oroitu
RECRUITING
Spain Madrid Hosp. Clinico San Carlos
RECRUITING
Spain Pamplona Clinica Univ. de Navarra
RECRUITING
Spain Pozuelo de Alarcón Hosp. Quiron Madrid Pozuelo
RECRUITING
Spain Terrassa Hosp. Mutua Terrassa
RECRUITING
Spain Zaragoza Hosp. Viamed Montecanal
RECRUITING
Sweden Stockholm Karolinska Universitetssjukhuset Huddinge
RECRUITING
United Kingdom Bath Royal United Hospital
RECRUITING
United Kingdom Birmingham Re-Cognition Health
RECRUITING
United Kingdom Bristol Re-Cognition Health
RECRUITING
United Kingdom Guildford Re-Cognition Health
RECRUITING
United Kingdom London Re-Cognition Health
RECRUITING
United Kingdom London Kings College Hospital
RECRUITING
United Kingdom Oxford University of Oxford
RECRUITING
United Kingdom Plymouth Re-Cognition Health
RECRUITING
United Kingdom Southampton Moorgreen Hospital Memory Assessment And Research Centre
RECRUITING
United Kingdom Southampton Southampton General Hospital
RECRUITING
United Kingdom Winchester Re-Cognition Health
RECRUITING
Japan Toyonaka-shi Jinsenkai MI Clinic
RECRUITING
Spain Barcelona Fund. Ace-Inst. Cat. Neuroc. Aplicades
RECRUITING
United Kingdom Edinburgh Scottish Brain Sciences
RECRUITING
Show More
Geo Locations

33.95335, -117.39616

32.71533, -117.15726

26.5909, -80.10088

28.54944, -81.77285

28.62778, -81.36312

28.53917, -80.672

28.53834, -81.37924

27.19755, -80.25283

26.65868, -80.24144

31.32712, -89.29034

43.06534, -76.07853

39.62839, -84.15938

40.10233, -75.27435

35.57779, 139.71685

34.81352, 135.64914

34.6913, 135.183

34.78244, 135.46932

33.44838, -112.07404

33.66946, -117.82311

26.3669, -80.13033

30.33218, -81.65565

28.91749, -81.92286

27.94752, -82.45843

28.93408, -81.95994

26.71534, -80.05337

41.85003, -87.65005

42.3703, -87.90202

42.48531, -83.37716

40.70491, -74.31723

42.65258, -73.75623

40.71427, -74.00597

35.11681, -80.72368

41.82399, -71.41283

29.42412, -98.49363

42.87813, -73.19677

38.02931, -78.47668

-37.8, 144.96667

-27.38472, 153.03062

-33.87939, 151.21925

-32.90038, 144.3015

-33.98333, 151.11667

-33.7751, 151.11272

-31.98184, 115.8073

43.60426, 1.44367

35.64837, 139.55426

34.6913, 135.183

35.74242, 139.42635

35.68184, 140.04152

35.2946, 139.57059

35.2946, 139.57059

35.6858974, 139.7208184

34.76143, 135.51567

41.38879, 2.15899

41.38879, 2.15899

43.35689, -3.01146

40.4165, -3.70256

42.81687, -1.64323

40.43293, -3.81338

41.56667, 2.01667

41.65606, -0.87734

59.33258, 18.0649

51.3751, -2.36172

52.48142, -1.89983

51.45523, -2.59665

51.23536, -0.57427

51.50853, -0.12574

51.50853, -0.12574

51.75222, -1.25596

50.37153, -4.14305

50.90395, -1.40428

50.90395, -1.40428

51.06513, -1.3187

34.78244, 135.46932

41.38879, 2.15899

55.95206, -3.19648

x
50

Indicates 50+ sites in this region: click to zoom in.

10

Indicates 10+ sites in this region: click to zoom in.

5

Indicates < 10 sites in this region: click to zoom in.

Corresponds to individual site.

Interested in participating?

×

Confirm


If you are interested in this clinical trial, we will use your email address to respond to your questions and fulfill your requests as necessary for our legitimate interest and possibly to comply with our legal obligations relating to pharmacovigilance. Please read our Privacy Policy.

Footer

  • PRIVACY POLICY
  • LEGAL NOTICE
  • COOKIE POLICY
  • COOKIE SETTINGS
  • CAREERS
  • NEWS CENTER
  • DO NOT SELL MY PERSONAL INFORMATION

Footer Social

Find Janssen Global on:

twitter youtube linkedin

Janssen Global Policy text

©Johnson & Johnson Innovative Medicine. All Rights Reserved. This website is hosted and operated by Johnson & Johnson Innovative Medicine, which is solely responsible for its content. This website is intended for a global audience.